|
|
||||||||||||||||||||||||||||||||||||||||||||||||||||
OS Therapies, Inc. operates as a clinical stage biopharmaceutical company. It engages in identification, development, and commercialization of treatments for Osteosarcoma and other related diseases. The company was founded by Paul A. Romness on April 12, 2018 and is headquartered in Rockville, MD. | ||||||||||||||||||||||||||||||||||||||||||||||||||||
open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR |